• Home
  • News
  • Fortune 500
  • Tech
  • Finance
  • Leadership
  • Lifestyle
  • Rankings
  • Multimedia
HealthCoronavirus

What are the potential long-term effects of having COVID-19?

By
The Associated Press
The Associated Press
Down Arrow Button Icon
By
The Associated Press
The Associated Press
Down Arrow Button Icon
June 16, 2020, 1:07 PM ET

Subscribe to Outbreak, a daily roundup of stories on the coronavirus pandemic and its impact on global business, delivered free to your inbox.

It’s hard to say exactly, because the coronavirus is still so new that scientists don’t know much about long-term effects. The best evidence comes from patients themselves, and some experience a variety of symptoms long after their infections have cleared.

Most people recover within a few weeks. For people who experience longer-term effects, the most common issues are bouts of exhaustion, headaches, anxiety and muscle aches that can last for at least several more weeks.

Patients who required intensive care, including those put on ventilators or kidney dialysis, can experience more serious issues.

Lung scarring can occur in people who developed pneumonia. Heart inflammation, irregular heartbeats, and worsening kidney and liver function have been reported as well. However, it’s too soon to know if those could be permanent problems.

Survivors who had long intensive-care stays sometimes need oxygen therapy or dialysis at home. Some also develop a condition called post-intensive care syndrome, which can include persistent muscle weakness and memory problems. That can happen after any critical illness and may be related to sedation and prolonged bed confinement during hospitalization.

Blood clots can also develop during and after COVID-19 infections, occasionally causing strokes. Even in less serious cases, blood thinners are prescribed and can require lifestyle changes to reduce risks of bleeding.

Most symptoms appear to eventually go away, said Dr. Thomas McGinn of the Feinstein Institutes for Medical Research in New York, who was involved in one of the largest U.S. studies of COVID-19 patients.

“It’s just a matter of when. For some patients it may take longer than others,” McGinn said.

About the Author
By The Associated Press
See full bioRight Arrow Button Icon
Rankings
  • 100 Best Companies
  • Fortune 500
  • Global 500
  • Fortune 500 Europe
  • Most Powerful Women
  • Future 50
  • World’s Most Admired Companies
  • See All Rankings
Sections
  • Finance
  • Leadership
  • Success
  • Tech
  • Asia
  • Europe
  • Environment
  • Fortune Crypto
  • Health
  • Retail
  • Lifestyle
  • Politics
  • Newsletters
  • Magazine
  • Features
  • Commentary
  • Mpw
  • CEO Initiative
  • Conferences
  • Personal Finance
  • Education
Customer Support
  • Frequently Asked Questions
  • Customer Service Portal
  • Privacy Policy
  • Terms Of Use
  • Single Issues For Purchase
  • International Print
Commercial Services
  • Advertising
  • Fortune Brand Studio
  • Fortune Analytics
  • Fortune Conferences
  • Business Development
About Us
  • About Us
  • Editorial Calendar
  • Press Center
  • Work At Fortune
  • Diversity And Inclusion
  • Terms And Conditions
  • Site Map

© 2025 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and Privacy Notice | Do Not Sell/Share My Personal Information
FORTUNE is a trademark of Fortune Media IP Limited, registered in the U.S. and other countries. FORTUNE may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.